Affordable Access

deepdyve-link
Publisher Website

May we target double-membrane vesicles and oxysterol-binding protein to combat SARS-CoV-2 infection?

Authors
  • Shahmohamadnejad, Shiva1
  • Nabavi, Seyed Fazel2, 3
  • Habtemariam, Solomon4
  • Sarkar, Kasturi5
  • Sil, Parames C6
  • Dowran, Razieh7
  • Nabavi, Seyed Mohammad2, 3
  • 1 Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. , (Iran)
  • 2 Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. , (Iran)
  • 3 Division of Translational Medicine, Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran. , (Iran)
  • 4 Pharmacognosy Research Laboratories & Herbal Analysis Services UK, University of Greenwich, Chatham-Maritime, Kent, UK.
  • 5 Department of Microbiology, St. Xavier's College, Kolkata, India. , (India)
  • 6 Department of Molecular Medicine, Bose Institute, Kolkata, India. , (India)
  • 7 Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. , (Iran)
Type
Published Article
Journal
Cell Biology International
Publisher
Wiley (John Wiley & Sons)
Publication Date
Sep 01, 2020
Volume
44
Issue
9
Pages
1770–1772
Identifiers
DOI: 10.1002/cbin.11400
PMID: 32449802
Source
Medline
Keywords
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times